Pennsylvania | 000-00121 | 23-1498399 | ||||||||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Common Stock, Without Par Value | KLIC | The Nasdaq Global Market |
Item 9.01 |
Financial Statements and Exhibits. |
|||||||
(d) | Exhibits. | |||||||
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Inline XBRL for the cover page of this Current Report on Form 8‑K. | |||||||
KULICKE AND SOFFA INDUSTRIES, INC. | |||||||||||
Date: January 31, 2024 | By: | /s/ LESTER WONG | |||||||||
Name: | Lester Wong | ||||||||||
Title: | Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) |
||||||||||
![]() |
Kulicke & Soffa Pte. Ltd.
23A Serangoon North Ave 5
Singapore 554369
+65 6880-9600 main
Co. Regn. No. 199902120H
|
||||
Kulicke and Soffa Industries, Inc.
1005 Virginia Drive
Fort Washington, PA 19034 USA
+1-215-784-6000 main
www.kns.com
|
Quarterly Results - U.S. GAAP | |||||||||||
Fiscal Q1 2024 |
Change vs. Fiscal Q1 2023 |
Change vs. Fiscal Q4 2023 |
|||||||||
Net Revenue | $171.2 million | down 2.9% | down 15.4% | ||||||||
Gross Margin | 46.7% | down 360 bps | down 70 bps | ||||||||
Income from Operations | $1.7 million | down 85.7% | down 91.3% | ||||||||
Operating Margin | 1.0% | down 570 bps | down 860 bps | ||||||||
Net Income | $9.3 million | down 36.3% | down 60.2% | ||||||||
Net Margin | 5.4% | down 290 bps | down 610 bps | ||||||||
EPS – Diluted | $0.16 | down 36% | down 61% |
Quarterly Results - Non-GAAP | |||||||||||
Fiscal Q1 2024 |
Change vs. Fiscal Q1 2023 |
Change vs. Fiscal Q4 2023 |
|||||||||
Income from Operations | $10.9 million | down 46.1% | down 58.5% | ||||||||
Operating Margin | 6.4% | down 510 bps | down 660 bps | ||||||||
Net Income | $17.0 million | down 22% | down 42.3% | ||||||||
Net Margin | 9.9% | down 250 bps | down 460 bps | ||||||||
EPS – Diluted | $0.30 | down 18.9% | down 41.2% |
Kulicke and Soffa Industries, Inc. | |||||
Joseph Elgindy | |||||
Finance | |||||
P: +1-215-784-7518 | |||||
Three months ended | |||||||||||
December 30, 2023 | December 31, 2022 | ||||||||||
Net revenue | $ | 171,189 | $ | 176,233 | |||||||
Cost of sales | 91,293 | 87,527 | |||||||||
Gross profit | 79,896 | 88,706 | |||||||||
Operating expenses: | |||||||||||
Selling, general and administrative | 40,046 | 40,500 | |||||||||
Research and development | 36,810 | 34,508 | |||||||||
Amortization of intangible assets | 1,347 | 1,394 | |||||||||
Acquisition-related costs | — | 107 | |||||||||
Restructuring | — | 375 | |||||||||
Total operating expenses | 78,203 | 76,884 | |||||||||
Income from operations | 1,693 | 11,822 | |||||||||
Other income (expense): | |||||||||||
Interest income | 9,899 | 6,559 | |||||||||
Interest expense | (22) | (34) | |||||||||
Income before income taxes | 11,570 | 18,347 | |||||||||
Income tax expense | 2,277 | 3,758 | |||||||||
Net income | $ | 9,293 | $ | 14,589 | |||||||
Net income per share: | |||||||||||
Basic | $ | 0.16 | $ | 0.26 | |||||||
Diluted | $ | 0.16 | $ | 0.25 | |||||||
Cash dividends declared per share | $ | 0.20 | $ | 0.19 | |||||||
Weighted average shares outstanding: | |||||||||||
Basic | 56,650 | 57,051 | |||||||||
Diluted | 57,023 | 57,729 |
Three months ended | |||||||||||
Supplemental financial data: | December 30, 2023 | December 31, 2022 | |||||||||
Depreciation and amortization | $ | 7,985 | $ | 5,613 | |||||||
Capital expenditures | 3,533 | 15,651 | |||||||||
Equity-based compensation expense: | |||||||||||
Cost of sales | 359 | 308 | |||||||||
Selling, general and administrative | 5,680 | 4,867 | |||||||||
Research and development | 1,818 | 1,346 | |||||||||
Total equity-based compensation expense | $ | 7,857 | $ | 6,521 |
As of | |||||||||||
December 30, 2023 | December 31, 2022 | ||||||||||
Number of employees | 2,981 | 3,176 |
As of | |||||||||||
December 30, 2023 | September 30, 2023 | ||||||||||
ASSETS | |||||||||||
CURRENT ASSETS | |||||||||||
Cash and cash equivalents | $ | 424,660 | $ | 529,402 | |||||||
Short-term investments | 285,000 | 230,000 | |||||||||
Accounts and other receivable, net of allowance for doubtful accounts of $49 and $49, respectively | 184,400 | 158,601 | |||||||||
Inventories, net | 236,558 | 217,304 | |||||||||
Prepaid expenses and other current assets | 47,035 | 53,751 | |||||||||
TOTAL CURRENT ASSETS | 1,177,653 | 1,189,058 | |||||||||
Property, plant and equipment, net | 107,273 | 110,051 | |||||||||
Operating right-of-use assets | 45,797 | 47,148 | |||||||||
Goodwill | 89,516 | 88,673 | |||||||||
Intangible assets, net | 28,916 | 29,357 | |||||||||
Deferred tax assets | 32,139 | 31,551 | |||||||||
Equity investments | 2,042 | 716 | |||||||||
Other assets | 3,390 | 3,223 | |||||||||
TOTAL ASSETS | $ | 1,486,726 | $ | 1,499,777 | |||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||
CURRENT LIABILITIES | |||||||||||
Accounts payable | 58,682 | 49,302 | |||||||||
Operating lease liabilities | 6,697 | 6,574 | |||||||||
Accrued expenses and other current liabilities | 91,193 | 103,005 | |||||||||
Income taxes payable | 24,716 | 22,670 | |||||||||
TOTAL CURRENT LIABILITIES | 181,288 | 181,551 | |||||||||
Deferred tax liabilities | 37,174 | 37,264 | |||||||||
Income taxes payable | 53,145 | 52,793 | |||||||||
Operating lease liabilities | 41,720 | 41,839 | |||||||||
Other liabilities | 12,148 | 11,769 | |||||||||
TOTAL LIABILITIES | 325,475 | 325,216 | |||||||||
SHAREHOLDERS' EQUITY | |||||||||||
Common stock, no par value | 578,479 | 577,727 | |||||||||
Treasury stock, at cost | (756,949) | (737,214) | |||||||||
Retained earnings | 1,353,800 | 1,355,810 | |||||||||
Accumulated other comprehensive loss | (14,079) | (21,762) | |||||||||
TOTAL SHAREHOLDERS' EQUITY | $ | 1,161,251 | $ | 1,174,561 | |||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ | 1,486,726 | $ | 1,499,777 |
Three months ended | |||||||||||
December 30, 2023 | December 31, 2022 | ||||||||||
Net cash (used in)/provided by operating activities | $ | (7,331) | $ | 85,116 | |||||||
Net cash used in investing activities | (60,541) | (38,914) | |||||||||
Net cash used in financing activities | (38,124) | (56,230) | |||||||||
Effect of exchange rate changes on cash and cash equivalents | 1,254 | 5,104 | |||||||||
Changes in cash and cash equivalents | (104,742) | (4,924) | |||||||||
Cash and cash equivalents, beginning of period | 529,402 | 555,537 | |||||||||
Cash and cash equivalents, end of period | $ | 424,660 | $ | 550,613 | |||||||
Short-term investments | 285,000 | 245,000 | |||||||||
Total cash, cash equivalents and short-term investments | $ | 709,660 | $ | 795,613 | |||||||
Three months ended | ||||||||||||||||||||
December 30, 2023 | December 31, 2022 | September 30, 2023 | ||||||||||||||||||
Net revenue | $ | 171,189 | $ | 176,233 | $ | 202,320 | ||||||||||||||
U.S. GAAP income from operations | 1,693 | 11,822 | 19,474 | |||||||||||||||||
U.S. GAAP operating margin | 1.0 | % | 6.7 | % | 9.6 | % | ||||||||||||||
Pre-tax non-GAAP items: | ||||||||||||||||||||
Amortization related to intangible assets | 1,347 | 1,394 | 1,356 | |||||||||||||||||
Restructuring | — | 375 | — | |||||||||||||||||
Equity-based compensation | 7,857 | 6,521 | 5,441 | |||||||||||||||||
Acquisition-related costs |
— | 107 | 13 | |||||||||||||||||
Non-GAAP income from operations | $ | 10,897 | $ | 20,219 | $ | 26,284 | ||||||||||||||
Non-GAAP operating margin | 6.4 | % | 11.5 | % | 13.0 | % | ||||||||||||||
Three months ended | ||||||||||||||||||||
December 30, 2023 | December 31, 2022 | September 30, 2023 | ||||||||||||||||||
Net revenue | $ | 171,189 | $ | 176,233 | $ | 202,320 | ||||||||||||||
U.S. GAAP net income | 9,293 | 14,589 | 23,357 | |||||||||||||||||
U.S. GAAP net margin | 5.4 | % | 8.3 | % | 11.5 | % | ||||||||||||||
Non-GAAP adjustments: | ||||||||||||||||||||
Amortization related to intangible assets | 1,347 | 1,394 | 1,356 | |||||||||||||||||
Restructuring | — | 375 | — | |||||||||||||||||
Equity-based compensation | 7,857 | 6,521 | 5,441 | |||||||||||||||||
Acquisition-related costs | — | 107 | 13 | |||||||||||||||||
Net income tax benefit on non-GAAP items | (1,516) | (1,218) | (758) | |||||||||||||||||
Total non-GAAP adjustments | $ | 7,688 | $ | 7,179 | $ | 6,052 | ||||||||||||||
Non-GAAP net income | $ | 16,981 | $ | 21,768 | $ | 29,409 | ||||||||||||||
Non-GAAP net margin | 9.9 | % | 12.4 | % | 14.5 | % | ||||||||||||||
U.S. GAAP net income per share: | ||||||||||||||||||||
Basic | 0.16 | 0.26 | 0.41 | |||||||||||||||||
Diluted(a) |
0.16 | 0.25 | 0.41 | |||||||||||||||||
Non-GAAP adjustments per share:(b) |
||||||||||||||||||||
Basic | 0.14 | 0.13 | 0.11 | |||||||||||||||||
Diluted | 0.14 | 0.12 | 0.10 | |||||||||||||||||
Non-GAAP net income per share: | ||||||||||||||||||||
Basic | $ | 0.30 | $ | 0.39 | $ | 0.52 | ||||||||||||||
Diluted(c) |
$ | 0.30 | $ | 0.37 | $ | 0.51 | ||||||||||||||
Weighted average shares outstanding: | ||||||||||||||||||||
Basic | 56,650 | 57,051 | 56,442 | |||||||||||||||||
Diluted | 57,023 | 57,729 | 57,408 | |||||||||||||||||
Three months ended | ||||||||||||||||||||
December 30, 2023 |
December 31, 2022 |
September 30, 2023 | ||||||||||||||||||
U.S. GAAP net cash (used in)/provided by operating activities | $ | (7,331) | $ | 85,116 | $ | 77,492 | ||||||||||||||
Expenditures for property, plant and equipment | (4,426) | (13,878) | (9,281) | |||||||||||||||||
Proceeds from sales of property, plant and equipment | — | — | 273 | |||||||||||||||||
Non-GAAP adjusted free cash flow | (11,757) | 71,238 | 68,484 | |||||||||||||||||
Second quarter of fiscal 2024 ending March 30, 2024 |
||||||||||||||||||||
GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||
Net revenue | $170 million +/- $10 million |
— | $170 million +/- $10 million |
|||||||||||||||||
Operating expenses | $79.3 million +/- 2% |
$6.8 million B,C |
$72.5 million
+/- 2%
|
|||||||||||||||||
Diluted EPS(1) |
$0.13 +/- 10% |
$0.12 A, B, C,D |
$0.25 +/- 10% |
|||||||||||||||||
Non-GAAP Adjustments | ||||||||||||||||||||
A. Equity-based compensation - Cost of sales |
0.4 | |||||||||||||||||||
B. Equity-based compensation - Selling, general and administrative and Research and development | 5.4 | |||||||||||||||||||
C. Amortization related to intangible assets |
1.4 | |||||||||||||||||||
D. Net income tax effect of the above items |
(0.5) | |||||||||||||||||||